ISONIAZID-RIFAMPIN REGIMENS FOR TUBERCULOSIS - REPLY

被引：0
|
作者：
BUECHNER, HA
机构：
来源：
ANNALS OF INTERNAL MEDICINE | 1981年 / 95卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：519 / 519
页数：1
相关论文
共 50 条
  • [41] COST EFFECTIVENESS ANALYSIS TO TREAT LATENT TUBERCULOSIS INFECTION: CAMPARING ISONIAZID, RIFAMPIN AND RIFAMPIN/PYRAZINAMIDE
    Sangani, D.
    VALUE IN HEALTH, 2010, 13 (03) : A191 - A191
  • [42] Minimum inhibitory concentrations of rifampin and isoniazid among multidrug and isoniazid resistant Mycobacterium tuberculosis in Ethiopia
    Getahun, Muluwork
    Blumberg, Henry M.
    Ameni, Gobena
    Beyene, Dereje
    Kempker, Russell R.
    PLOS ONE, 2022, 17 (09):
  • [43] Long-term efficacy of 6-month therapy with isoniazid and rifampin compared with isoniazid, rifampin, and pyrazinamide treatment for pleural tuberculosis
    Francisco Garcia-Rodriguez, Jose
    Valcarce-Pardeiro, N.
    Alvarez-Diaz, H.
    Marino-Callejo, A.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2019, 38 (11) : 2121 - 2126
  • [44] Long-term efficacy of 6-month therapy with isoniazid and rifampin compared with isoniazid, rifampin, and pyrazinamide treatment for pleural tuberculosis
    José Francisco García-Rodríguez
    N. Valcarce-Pardeiro
    H. Álvarez-Díaz
    A. Mariño-Callejo
    European Journal of Clinical Microbiology & Infectious Diseases, 2019, 38 : 2121 - 2126
  • [45] Rifapentine and Isoniazid for Latent Tuberculosis REPLY
    Sterling, Timothy R.
    Moro, Ruth
    Villarino, M. Elsa
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (15): : 1448 - 1448
  • [46] Hepatotoxicity of rifampin-pyrazinamide and isoniazid preventive therapy and tuberculosis treatment
    van Hest, R
    Baars, H
    Kik, S
    van Gerven, P
    Trompenaars, MC
    Kalisvaart, N
    Keizer, S
    Borgdorff, M
    Mensen, M
    Cobelens, F
    CLINICAL INFECTIOUS DISEASES, 2004, 39 (04) : 488 - 496
  • [47] STABILITY OF ISONIAZID, RIFAMPIN AND PYRAZINAMIDE IN SUSPENSIONS USED FOR THE TREATMENT OF TUBERCULOSIS IN CHILDREN
    SEIFART, HI
    PARKIN, DP
    DONALD, PR
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1991, 10 (11) : 827 - 831
  • [48] Outcome of chemotherapy in 107 patients with pulmonary tuberculosis resistant to isoniazid and rifampin
    Park, SK
    Kim, CT
    Song, SD
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 1998, 2 (11) : 877 - 884
  • [49] Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults
    Menzies, D.
    Adjobimey, M.
    Ruslami, R.
    Trajman, A.
    Sow, O.
    Kim, H.
    Baah, J. Obeng
    Marks, G. B.
    Long, R.
    Hoeppner, V.
    Elwood, K.
    Al-Jahdali, H.
    Gninafon, M.
    Apriani, L.
    Koesoemadinata, R. C.
    Kritski, A.
    Rolla, V.
    Bah, B.
    Camara, A.
    Boakye, I.
    Cook, V. J.
    Goldberg, H.
    Valiquette, C.
    Hornby, K.
    Dion, M. -J.
    Li, P. -Z.
    Hill, P. C.
    Schwartzman, K.
    Benedetti, A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (05): : 440 - 453
  • [50] Determinants of rifampin, isoniazid, pyrazinamide, and ethambutol pharmacokinetics in a cohort of tuberculosis patients
    McIlleron, H
    Wash, P
    Burger, A
    Norman, J
    Folb, PI
    Smith, P
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (04) : 1170 - 1177
12345